Akamai Technologies vs MSCI
AKAM and MSCI side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AKAM and MSCI compare
MSCI is the larger company, worth 3.4 times as much as Akamai Technologies ($45.3B against $13.3B).
On earnings, Akamai Technologies is cheaper: it trades at 33.4× trailing earnings, against 34.1× for MSCI.
MSCI grew revenue faster over the last twelve months (11.6% versus 5.9% for Akamai Technologies).
MSCI keeps more of each dollar of sales as profit, with a net margin of 40.7% compared with 9.5% at Akamai Technologies.
MSCI pays a dividend yielding 1.3%; Akamai Technologies does not pay one.
MSCI scores higher on the StockData Score (19 against 10 for Akamai Technologies), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AKAM | MSCI |
|---|---|---|
| Size and price | ||
| Market cap | $13.3B | $45.3B |
| Share price | $92.72 | $623.38 |
| Change, 1 year | 27.0% | 9.8% |
| Change, 5 years | −13.6% | −4.6% |
| Beta (5Y) | 0.83 | 1.18 |
| Employees | 11K | 6,268 |
| StockData Score | ||
| Total score | 10 | 19 (better) |
| Valuation score | 2 | 2 |
| Growth score | 0 | 6 (better) |
| Performance score | 3 | 4 (better) |
| Health score | 5 (better) | 3 |
| Dividend score | 0 | 4 (better) |
| Valuation | ||
| P/E | 33.4× (better) | 34.1× |
| P/S | 3.1× (better) | 13.6× |
| P/B | 2.8× | – |
| EV/EBITDA | 8.4× (better) | 27.3× |
| P/FCF | 13.9× (better) | 28.4× |
| PEG | – | 2.52 |
| FCF yield | 7.2% (better) | 3.5% |
| Fair value | $96.48 | $576.32 |
| Margin of safety | 3.9% (better) | −8.2% |
| Growth | ||
| Revenue growth (TTM) | 5.9% | 11.6% (better) |
| Revenue growth, 5Y average | 5.6% | 13.1% (better) |
| Net income growth (TTM) | −3.2% | 15.2% (better) |
| EPS growth (TTM) | −1.4% | 21.1% (better) |
| EPS growth, 5Y average | −1.8% | 17.1% (better) |
| Profitability | ||
| Gross margin | 57.5% | 83.0% (better) |
| Operating margin | 10.5% | 55.7% (better) |
| Net margin | 9.5% | 40.7% (better) |
| FCF margin | 22.1% | 47.9% (better) |
| Return on equity | 8.9% | – |
| Return on invested capital | 15.3% | 47.9% (better) |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Net debt / EBITDA | – | 3.20 |
| Interest coverage | 13.7× (better) | 7.2× |
| Current ratio | 1.64 (better) | 0.89 |
| Altman Z-score | 1.64 | 6.40 (better) |
| Piotroski F-score | 7 | 8 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 1.3% |
| Payout ratio | – | 42.2% |
| Years of dividend growth | – | 11 |
| Dividend growth, 5Y average | – | 19.8% |
| Buyback yield | 4.6% | 6.0% (better) |
| Shareholder yield | 4.6% | 7.3% (better) |
| Ownership | ||
| Held by institutions | 111% | 92.8% |
| Held by insiders | 2.2% | 3.6% |
| Insider net buying, 12 months | −$17.1M | $8.5M (better) |
| Superinvestors holding | – | 4 |
| Short interest, % of float | 13.7% | 2.8% |
Go deeper
- AKAM stock overview
- AKAM income statement
- AKAM valuation and score
- MSCI stock overview
- MSCI income statement
- MSCI valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.